Hydrocholorquin

Markiert sind besonders wichtige Quellen.

• Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

  thelancet.com, hinzugefügt am 13.05.2022

• Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE – Coalition V): A double-blind, multicentre, randomised, controlled trial

  thelancet.com, hinzugefügt am 03.04.2022

• Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients

  rcm.imrpress.com, hinzugefügt am 04.10.2021

• Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial (HERO-HCQ)

  medrxiv.org, hinzugefügt am 28.08.2021

• Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19

  jamanetwork.com, hinzugefügt am 24.04.2021

• Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

  nature.com, hinzugefügt am 17.04.2021

• Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2

  journals.plos.org, hinzugefügt am 22.01.2021

• Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19

  ncbi.nlm.nih.gov, hinzugefügt am 17.01.2021

• Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study

  bmcinfectdis.biomedcentral.com, hinzugefügt am 16.01.2021

• Henry Ford study on hydroxychloroquine for COVID quietly shut down

  bridgemi.com, hinzugefügt am 12.01.2021

• Comparing ICU Admission Rates of Mild/Moderate COVID-19 Patients Treated with Hydroxychloroquine, Favipiravir, and Hydroxychloroquine plus Favipiravir

  sciencedirect.com, hinzugefügt am 30.12.2020

• Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin

  sciencedirect.com, hinzugefügt am 14.12.2020

• Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational study

  sciencedirect.com, hinzugefügt am 13.12.2020

• Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: prospective, non-randomized trial

  sciencedirect.com, hinzugefügt am 10.12.2020

• Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection

  acpjournals.org, hinzugefügt am 09.12.2020

• HCQ is effective for COVID-19 when used early: analysis of 152 studies

  hcqmeta.com, hinzugefügt am 02.12.2020

• Hydroxychloroquin und Chloroquin: Arzneimittelbehörden warnen vor psychiatrischen Nebenwirkungen

  aerzteblatt.de, hinzugefügt am 01.12.2020

• A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19 List of authors.

  nejm.org, hinzugefügt am 26.11.2020

• Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19

  sciencedirect.com, hinzugefügt am 22.11.2020

• Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19

  jamanetwork.com, hinzugefügt am 11.11.2020

• Misguided Use of Hydroxychloroquine for COVID-19

  jamanetwork.com, hinzugefügt am 11.11.2020

• Hydroxychloroquine does not benefit adults hospitalized with COVID-19

  nih.gov, hinzugefügt am 10.11.2020

• Post Exposure Prophylaxis

  sciencedirect.com, hinzugefügt am 07.11.2020

• pre-exposure use of hydroxychloroquine

  thelancet.com, hinzugefügt am 06.11.2020

• Low dose hydroxychloroquine is associated with lower mortality in COVID-19:

  medrxiv.org, hinzugefügt am 05.11.2020

• SOLIDARITY data

  blogs.sciencemag.org, hinzugefügt am 01.11.2020

• Covid-19 Outpatients

  sciencedirect.com, hinzugefügt am 01.11.2020

• Hydrochloroquine

  nature.com, hinzugefügt am 01.11.2020

• SOLIDARITY trial

  medrxiv.org, hinzugefügt am 01.11.2020

Keine Quelle enthält diesen Text.